STARTUP TACKLES AI DRUG DISCOVERY BOTTLENECK

10x Science has secured $4.8 million in seed funding to help pharmaceutical researchers interpret the flood of AI-generated molecular candidates. The startup addresses a critical gap: AI can propose drugs faster than humans can evaluate them.